Aurélie Kas

Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial

Stéphane Palfi, Jean Marc Gurruchaga, G. Ralph et al. · The Lancet · 2014 · 432 citations

Gene Therapies, Neurodegenerative Diseases, Dose Escalation +11

Neural correlates of cognitive impairment in posterior cortical atrophy

Aurélie Kas, Leonardo Cruz de Souza, Dalila Samri et al. · Brain · 2011 · 176 citations · Full text

Deciphering logopenic primary progressive aphasia: a clinical, imaging and biomarker investigation

Marc Teichmann, Aurélie Kas, Claire Boutet et al. · Brain · 2013 · 171 citations · Full text

Neuropsychology, Corticobasal Degeneration, Neurolinguistics +30

Is ¹⁸F‐fluorodeoxyglucose positron emission tomography scanning a reliable way to assess disease activity in takayasu arteritis?

Laurent Arnaud, Julien Haroche, Zoulikha Malek et al. · Arthritis & Rheumatism · 2009 · 164 citations

Vasculitis, Pet-mri, Diagnosis +23

¹⁸F‐fluorodeoxyglucose–positron emission tomography scanning is more useful in followup than in the initial assessment of patients with Erdheim‐Chester disease

Laurent Arnaud, Zoulikha Malek, F. Archambaud et al. · Arthritis & Rheumatism · 2009 · 108 citations